Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-25-112232

Options or other derivatives

  • Director acquired 366,000 shares (grant or award)
  • Director returned 366,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −108,000 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +108,000 108,000 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −108,000 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +108,000 108,000 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −15,975 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +15,975 15,975 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −19,025 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +19,025 19,025 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −35,000 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +35,000 35,000 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −35,000 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +35,000 35,000 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −32,500 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +32,500 32,500 D
Juda Scott Director 2025-11-18 Returned to the company · Stock Option (right to buy) −12,500 0 D
Juda Scott Director 2025-11-18 Grant or award · Stock Option (right to buy) +12,500 12,500 D
Loading xslF345X05/ownership.xml…